Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
eVenus Pharmaceutical Laboratories
Princeton, New Jersey, United States
- Ownership
- Private
- Employees
- ~21
- Development stage
- Other
01
Overview
eVenus Pharmaceutical Laboratories has at least one approved product (oteseconazole for vulvovaginal candidiasis), and other programs in late-stage or commercial, with a focus on generics and affordable medicines. Some marketed products are present in the US, such as generic irinotecan for oncology via partnership with Prodigy Generics; pipeline includes additional small molecule drugs targeting infectious and urogenital diseases as well as ophthalmic conditions.
- Therapeutic areas
- Infectious DiseasesOphthalmology
- Modalities
- Small moleculeLipid
- Industry
- Biotech
02
Partnerships
Prodigy Health Supplier Corporation
Beyond the preview
Go deeper on eVenus Pharmaceutical Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on eVenus Pharmaceutical Laboratories.